Seres Therapeutics, Inc.
Status: Publicly traded
Direct answer
Seres Therapeutics, Inc. is publicly traded on NASDAQ under the ticker MCRB.
Seres Therapeutics, Inc. is a pioneering microbiome therapeutics firm dedicated to engineering bacterial consortia that modulate host cells and tissues to combat various diseases. Their flagship therapeutic, SER-109, an oral microbiome treatment, has successfully concluded Phase III clinical trials for the management of Clostridioides difficile infection (CDI). The company's pipeline further encompasses SER-155, a...
Can you invest in Seres Therapeutics, Inc.?
Yes. Seres Therapeutics, Inc. trades publicly on NASDAQ as MCRB.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Seres Therapeutics, Inc.
Detailed equity research is provided by MarketSnap.